¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05
±³À°ÀÏÀÚ : 2022-03-05
±³À°Àå¼Ò : ºÎ»êBPEX  
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  
À̸ÞÀÏ : office@thyroid.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:30~08:50 Role of Serum TSH in Active Surveillance of PTMC  ±èÇýÀÎ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 08:50~09:10 Tumor Volume Doubling Time in Active Surveillance of PTMC  ±è¿ø¹è(¿ï»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:10~09:30 Interim Analysis of MAeSTro  ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 09:30~09:40 ÅäÀÇ  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 09:40~10:00 Characterizing Dedifferentiation of Thyroid Cancer by Single Cell RNA Seqencing  ¹ÚÁöȯ(GIST) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:00~10:20 Diagnositc Approach in Thyroid Disease using Biometric Wearable Devices  ¹®ÀçÈÆ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 10:20~10:40 Artificial intelligence in Diagnosis of Thyroid Cancer   ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 10:40~10:50 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 10:50~11:10 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 11:10~12:10 Diagnostic, Prognostic and Predictive Factors in Differentiated Thyroid Carcinomas: From Morphology to Biomarker Studies  Ozgur Mete(Toronto General Hospital: University Health Network Canada) 
±âŸ 03-05 À̺¥Æ®È¦A&B 12:10~12:40 ÃÑȸ  () 
½Ä»ç 03-05 À̺¥Æ®È¦A&B 12:40~13:40 Á¡½É ½Ä»ç  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 13:40~14:20 ¹æ»ç¼º¿ä¿Àµå Ä¡·á¿Í 2Â÷¾Ï  ÀÌÀçÅÂ(°æºÏÀÇ´ë ÇÙÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:20~14:40 NIRAF in Thyroid Surgery  ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 14:40~15:00 New Imaging Techniques (Photoaccoustic Image, Laser Speckle, Next USG)  ±èÁö¼ö(ºÎ»ê´ë ³ª³ë°úÇбâ¼ú´ë) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:00~15:20 Percutaneous Neuromonitoring  À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú) 
Åä·Ð 03-05 À̺¥Æ®È¦A&B 15:20~15:30 ÅäÀÇ  () 
È޽Ġ03-05 À̺¥Æ®È¦A&B 15:30~15:50 Coffee Break  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦A&B 15:50~16:50 Serial Studies of Apatinib in Patients with Radioiodine Refractory Thyroid Cancer  Yansong Lin(Peking Union Medical College Hospital China) 
±âŸ 03-05 À̺¥Æ®È¦A&B 16:50~17:50 Topic Highlight  () 
±âŸ 03-05 À̺¥Æ®È¦D 08:30~09:40 Free Paper 3  () 
±âŸ 03-05 À̺¥Æ®È¦D 09:40~10:50 Free Paper 4  () 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:20~14:40 °©»ó¼± ÃÊÀ½ÆÄ ±Þ¿©È­  ÇѼö¿¬(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 14:40~15:00 ¼ö¼úÀå CCTV - º´ÇùÀÔÀå  ¼ÛÀçÂù(´ëÇѺ´¿øÇùȸ ºÎȸÀå) 
±³À°½Ã°£ 03-05 À̺¥Æ®È¦D 15:00~15:20 ¼ö¼úÀå CCTV - ÀÇÇùÀÔÀå  ±èÁ¾¹Î(´ëÇÑÀÇ»çÇùȸ º¸ÇèÀÌ»ç) 
Åä·Ð 03-05 À̺¥Æ®È¦D 15:20~15:30 ÅäÀÇ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-03-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°è¿¬¼ö°­Á : 2022-03-05
´ÙÀ½±Û ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼± ÃÊÀ½ÆÄ Hands-On Course : 2022-03-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 4 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 3 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 6 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 3 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 1 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 1 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 1 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 2 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 3 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 1 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 3 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 1 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷